Balschi JA |
In vivo clinical measures of intermediary metabolism are inadequate: can a new magnetic resonance spectroscopy technology do better? |
2012 |
Circ Cardiovasc Imaging |
pmid:22438422
|
Schroeder MA et al. |
The cycling of acetyl-coenzyme A through acetylcarnitine buffers cardiac substrate supply: a hyperpolarized 13C magnetic resonance study. |
2012 |
Circ Cardiovasc Imaging |
pmid:22238215
|
Malaguarnera M |
Carnitine derivatives: clinical usefulness. |
2012 |
Curr. Opin. Gastroenterol. |
pmid:22333562
|
Patel SP et al. |
Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery. |
2012 |
Neuroscience |
pmid:22445934
|
Zhang R et al. |
Neuroprotective effects of pre-treatment with l-carnitine and acetyl-L-carnitine on ischemic injury in vivo and in vitro. |
2012 |
Int J Mol Sci |
pmid:22408439
|
Hu C et al. |
Inhibition of OCTN2-mediated transport of carnitine by etoposide. |
2012 |
Mol. Cancer Ther. |
pmid:22389472
|
Wu R et al. |
Metabolomic analysis reveals that carnitines are key regulatory metabolites in phase transition of the locusts. |
2012 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:22328148
|
Boss A et al. |
Skeletal muscle ¹H MRSI before and after prolonged exercise. II. visibility of free carnitine. |
2012 |
Magn Reson Med |
pmid:22287218
|
Pochini L et al. |
The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease. |
2012 |
Biochim. Biophys. Acta |
pmid:22206629
|
Behrend AM et al. |
Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation. |
2012 |
Mol. Genet. Metab. |
pmid:22030098
|